SATB2SATB homeobox 2
Autism Reports / Total Reports
13 / 49Rare Variants / Common Variants
169 / 1Aliases
SATB2, FLJ21474, FLJ32076, KIAA1034, MGC119474, MGC119477Associated Syndromes
SATB2-associated syndrome, Glass syndrome, Glass syndrome, DD/ID, Glass syndrome, DD, IDChromosome Band
2q33.1Associated Disorders
DD/NDD, ID, EP, EPS, ASDGenetic Category
Rare Single Gene Mutation, Syndromic, Genetic Association, FunctionalRelevance to Autism
This gene was identified as an ASD candidate gene following the identification of a balanced chromosomal abnormality (BCA) leading to gene disruption in an ASD case (Talkowski et al., 2012). This BCA-disrupted gene was also individually implicated by case-control CNV burden or by a minimum of 3 CNVs in neuodevelopmental disorder (NDD) cases with none in controls in a follow-up study in the same report.
Molecular Function
This gene encodes a DNA binding protein that specifically binds nuclear matrix attachment regions. The encoded protein is involved in transcription regulation and chromatin remodeling. Defects in this gene are associated with isolated cleft palate and mental retardation.
External Links
SFARI Genomic Platforms
Reports related to SATB2 (49 Reports)
# | Type | Title | Author, Year | Autism Report | Associated Disorders |
---|---|---|---|---|---|
1 | Support | Heterozygous nonsense mutation SATB2 associated with cleft palate, osteoporosis, and cognitive defects | Leoyklang P , et al. (2007) | No | Epilepsy |
2 | Primary | Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries | Talkowski ME , et al. (2012) | Yes | - |
3 | Support | Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study | Rauch A , et al. (2012) | No | Epilepsy, ASD |
4 | Support | Detection of clinically relevant genetic variants in autism spectrum disorder by whole-genome sequencing | Jiang YH , et al. (2013) | Yes | - |
5 | Support | Further delineation of the SATB2 phenotype | Dcker D , et al. (2013) | No | - |
6 | Support | Refining analyses of copy number variation identifies specific genes associated with developmental delay | Coe BP , et al. (2014) | Yes | - |
7 | Support | Large-scale discovery of novel genetic causes of developmental disorders | Deciphering Developmental Disorders Study (2014) | No | Epilpesy/seizures, delayed or absent speech |
8 | Support | Further supporting evidence for the SATB2-associated syndrome found through whole exome sequencing | Zarate YA , et al. (2015) | No | DD, ID |
9 | Recent Recommendation | A molecular model for neurodevelopmental disorders | Gigek CO , et al. (2015) | No | - |
10 | Support | Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability | Lelieveld SH et al. (2016) | No | - |
11 | Recent Recommendation | SATB2-associated syndrome: Mechanisms, phenotype, and practical recommendations | Zarate YA and Fish JL (2016) | No | - |
12 | Support | The genomic landscape of balanced cytogenetic abnormalities associated with human congenital anomalies | Redin C , et al. (2016) | Yes | - |
13 | Support | Clinical exome sequencing: results from 2819 samples reflecting 1000 families | Trujillano D , et al. (2016) | No | ASD, DD, epilepsy/seizures |
14 | Support | Genotype and phenotype in 12 additional individuals with SATB2-associated syndrome | Zarate YA , et al. (2017) | No | DD, ID |
15 | Support | Clinical and molecular consequences of disease-associated de novo mutations in SATB2 | Bengani H , et al. (2017) | No | - |
16 | Support | A clinical utility study of exome sequencing versus conventional genetic testing in pediatric neurology | Vissers LE , et al. (2017) | No | - |
17 | Support | Genomic diagnosis for children with intellectual disability and/or developmental delay | Bowling KM , et al. (2017) | No | - |
18 | Support | Hotspots of missense mutation identify neurodevelopmental disorder genes and functional domains | Geisheker MR , et al. (2017) | Yes | - |
19 | Support | Using medical exome sequencing to identify the causes of neurodevelopmental disorders: Experience of 2 clinical units and 216 patients | Chrot E , et al. (2017) | No | - |
20 | Recent Recommendation | Natural history and genotype-phenotype correlations in 72 individuals with SATB2-associated syndrome | Zarate YA , et al. (2018) | No | DD |
21 | Positive Association | Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection | Pardias AF , et al. (2018) | No | - |
22 | Support | Genes regulated by SATB2 during neurodevelopment contribute to schizophrenia and educational attainment | Whitton L , et al. (2018) | No | - |
23 | Support | Genome sequencing identifies multiple deleterious variants in autism patients with more severe phenotypes | Guo H , et al. (2018) | Yes | - |
24 | Support | Whole genome paired-end sequencing elucidates functional and phenotypic consequences of balanced chromosomal rearrangement in patients with developmental disorders | Schluth-Bolard C , et al. (2019) | No | - |
25 | Support | The combination of whole-exome sequencing and copy number variation sequencing enables the diagnosis of rare neurological disorders | Jiao Q , et al. (2019) | No | - |
26 | Recent Recommendation | Mutation update for the SATB2 gene | Zarate YA , et al. (2019) | No | Autistic behavior |
27 | Support | Characterization of intellectual disability and autism comorbidity through gene panel sequencing | Aspromonte MC , et al. (2019) | Yes | - |
28 | Support | Exome sequencing of 457 autism families recruited online provides evidence for autism risk genes | Feliciano P et al. (2019) | Yes | - |
29 | Support | Astrocyte layers in the mammalian cerebral cortex revealed by a single-cell in situ transcriptomic map | Bayraktar OA et al. (2020) | No | - |
30 | Support | Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders | Wang T et al. (2020) | Yes | ID |
31 | Support | - | Zarate YA et al. (2021) | No | Epilepsy/seizures |
32 | Support | - | Abe-Hatano C et al. (2021) | No | - |
33 | Support | - | Hiraide T et al. (2021) | No | - |
34 | Support | - | Zarate YA et al. (2021) | No | ASD |
35 | Support | - | Pode-Shakked B et al. (2021) | Yes | - |
36 | Support | - | Mahjani B et al. (2021) | Yes | - |
37 | Support | - | Aguilera C et al. (2021) | No | - |
38 | Support | - | Mouillé M et al. (2022) | No | ASD |
39 | Support | - | Bissell S et al. (2022) | No | - |
40 | Support | - | Levchenko O et al. (2022) | No | Epilepsy/seizures |
41 | Support | - | Zhou X et al. (2022) | Yes | - |
42 | Support | - | Shimelis H et al. (2023) | No | - |
43 | Support | - | Copelli MM et al. (2023) | No | Autistic features |
44 | Support | - | Sanchis-Juan A et al. (2023) | No | - |
45 | Support | - | Nico Wahl et al. (2024) | No | - |
46 | Support | - | Alistair T Pagnamenta et al. (2024) | No | - |
47 | Support | - | Axel Schmidt et al. (2024) | No | ID, cognitive impairment |
48 | Support | - | Jianfen Yang et al. (2024) | No | - |
49 | Support | - | Karen Lob et al. () | Yes | DD, ID |
Rare Variants (169)
Status | Allele Change | Residue Change | Variant Type | Inheritance Pattern | Parental Transmission | Family Type | PubMed ID | Author, Year |
---|---|---|---|---|---|---|---|---|
- | - | inversion | De novo | - | - | 27841880 | Redin C , et al. (2016) | |
- | - | translocation | De novo | - | - | 27841880 | Redin C , et al. (2016) | |
- | - | copy_number_loss | De novo | - | - | 33381861 | Zarate YA et al. (2021) | |
- | - | copy_number_loss | Unknown | - | - | 33381861 | Zarate YA et al. (2021) | |
- | - | copy_number_loss | Unknown | - | - | 29436146 | Zarate YA , et al. (2018) | |
- | - | copy_number_loss | De novo | - | - | 31021519 | Zarate YA , et al. (2019) | |
- | - | copy_number_loss | Unknown | - | - | 31021519 | Zarate YA , et al. (2019) | |
- | - | translocation | De novo | - | - | 22521361 | Talkowski ME , et al. (2012) | |
- | - | frameshift_variant | De novo | - | - | 31021519 | Zarate YA , et al. (2019) | |
- | - | copy_number_gain | - | - | Multiplex | 29436146 | Zarate YA , et al. (2018) | |
- | - | copy_number_loss | De novo | - | - | 35241104 | Mouillé M et al. (2022) | |
c.-313C>T | - | stop_gained | De novo | - | - | 29436146 | Zarate YA , et al. (2018) | |
c.-561T>G | - | missense_variant | Unknown | - | - | 31021519 | Zarate YA , et al. (2019) | |
c.-2del | - | frameshift_variant | De novo | - | - | 28139846 | Zarate YA , et al. (2017) | |
c.1174-2A>G | - | splice_site_variant | De novo | - | - | 33004838 | Wang T et al. (2020) | |
c.347-16019C>T | - | missense_variant | De novo | - | - | 30945278 | Jiao Q , et al. (2019) | |
- | - | complex_structural_alteration | De novo | - | - | 27841880 | Redin C , et al. (2016) | |
c.-336del | - | frameshift_variant | De novo | - | - | 28139846 | Zarate YA , et al. (2017) | |
c.-418del | - | frameshift_variant | De novo | - | - | 28139846 | Zarate YA , et al. (2017) | |
c.-484del | - | frameshift_variant | De novo | - | - | 31021519 | Zarate YA , et al. (2019) | |
- | - | inversion | De novo | - | Simplex | 38776926 | Alistair T Pagnamenta et al. (2024) | |
c.-342del | - | splice_site_variant | Unknown | - | - | 31021519 | Zarate YA , et al. (2019) | |
c.124G>T | p.Gly42Ter | stop_gained | De novo | - | - | 28139846 | Zarate YA , et al. (2017) | |
c.-10_-9del | - | frameshift_variant | De novo | - | - | 29436146 | Zarate YA , et al. (2018) | |
c.181C>T | p.Pro61Ser | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.847C>T | p.Arg283Ter | stop_gained | De novo | - | - | 28139846 | Zarate YA , et al. (2017) | |
c.390T>A | p.Tyr130Ter | stop_gained | De novo | - | - | 28151491 | Bengani H , et al. (2017) | |
c.346G>T | p.Gly116Ter | stop_gained | De novo | - | - | 29436146 | Zarate YA , et al. (2018) | |
c.715C>T | p.Arg239Ter | stop_gained | Unknown | - | - | 29436146 | Zarate YA , et al. (2018) | |
c.715C>T | p.Arg239Ter | stop_gained | De novo | - | - | 31021519 | Zarate YA , et al. (2019) | |
c.715C>T | p.Arg239Ter | stop_gained | Unknown | - | - | 31021519 | Zarate YA , et al. (2019) | |
c.847C>T | p.Arg283Ter | stop_gained | De novo | - | - | 31021519 | Zarate YA , et al. (2019) | |
c.868C>T | p.Gln290Ter | stop_gained | De novo | - | - | 31021519 | Zarate YA , et al. (2019) | |
c.868C>T | p.Gln290Ter | stop_gained | Unknown | - | - | 31021519 | Zarate YA , et al. (2019) | |
c.988C>T | p.Gln330Ter | stop_gained | De novo | - | - | 31021519 | Zarate YA , et al. (2019) | |
c.997C>T | p.Gln333Ter | stop_gained | De novo | - | - | 31021519 | Zarate YA , et al. (2019) | |
c.715C>T | p.Arg239Ter | stop_gained | De novo | - | - | 37107640 | Copelli MM et al. (2023) | |
c.347-15097C>T | - | missense_variant | De novo | - | - | 31021519 | Zarate YA , et al. (2019) | |
c.347-15107T>G | - | missense_variant | De novo | - | - | 31021519 | Zarate YA , et al. (2019) | |
c.347-15120A>G | - | missense_variant | De novo | - | - | 31021519 | Zarate YA , et al. (2019) | |
c.1174-2A>G | - | splice_site_variant | De novo | - | - | 29436146 | Zarate YA , et al. (2018) | |
c.962T>C | p.Ile321Thr | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.1255C>T | p.Gln419Ter | stop_gained | De novo | - | - | 28139846 | Zarate YA , et al. (2017) | |
c.1285C>T | p.Arg429Ter | stop_gained | De novo | - | - | 28151491 | Bengani H , et al. (2017) | |
c.2074G>T | p.Glu692Ter | stop_gained | De novo | - | - | 28151491 | Bengani H , et al. (2017) | |
c.1285C>T | p.Arg429Ter | stop_gained | De novo | - | - | 29436146 | Zarate YA , et al. (2018) | |
c.1375C>T | p.Arg459Ter | stop_gained | Unknown | - | - | 29436146 | Zarate YA , et al. (2018) | |
c.1495A>T | p.Lys499Ter | stop_gained | De novo | - | - | 29436146 | Zarate YA , et al. (2018) | |
c.1135C>T | p.Gln379Ter | stop_gained | De novo | - | - | 31021519 | Zarate YA , et al. (2019) | |
c.1285C>T | p.Arg429Ter | stop_gained | De novo | - | - | 31021519 | Zarate YA , et al. (2019) | |
c.1375C>T | p.Arg459Ter | stop_gained | De novo | - | - | 31021519 | Zarate YA , et al. (2019) | |
c.1756C>T | p.Gln586Ter | stop_gained | Unknown | - | - | 31021519 | Zarate YA , et al. (2019) | |
c.688A>T | p.Lys230Ter | stop_gained | De novo | - | - | 28333917 | Vissers LE , et al. (2017) | |
c.225T>A | p.Tyr75Ter | stop_gained | De novo | - | - | 39039281 | Axel Schmidt et al. (2024) | |
c.1166G>A | p.Arg389His | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.1214G>A | p.Arg405Gln | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.1286G>A | p.Arg429Gln | missense_variant | De novo | - | - | 33004838 | Wang T et al. (2020) | |
c.1595G>A | p.Arg532His | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.1627C>T | p.Arg543Cys | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.1195C>G | p.Arg399Gly | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.1321A>G | p.Met441Val | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.1637A>T | p.Asn546Ile | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.347-14931del | - | frameshift_variant | Unknown | - | - | 28139846 | Zarate YA , et al. (2017) | |
c.347-14632del | - | frameshift_variant | De novo | - | - | 29436146 | Zarate YA , et al. (2018) | |
c.347-15067dup | - | frameshift_variant | Unknown | - | - | 29436146 | Zarate YA , et al. (2018) | |
c.347-15146del | - | frameshift_variant | De novo | - | - | 29436146 | Zarate YA , et al. (2018) | |
c.-573_-555del | - | frameshift_variant | De novo | - | - | 31021519 | Zarate YA , et al. (2019) | |
c.347-15004del | - | frameshift_variant | Unknown | - | - | 31021519 | Zarate YA , et al. (2019) | |
c.347-15019del | - | frameshift_variant | De novo | - | - | 31021519 | Zarate YA , et al. (2019) | |
c.347-15163del | - | frameshift_variant | De novo | - | - | 31021519 | Zarate YA , et al. (2019) | |
c.347-15988del | - | frameshift_variant | De novo | - | - | 31021519 | Zarate YA , et al. (2019) | |
c.1495A>T | p.Lys499Ter | stop_gained | De novo | - | - | 28554332 | Bowling KM , et al. (2017) | |
c.715C>T | p.Arg239Ter | stop_gained | De novo | - | - | 17377962 | Leoyklang P , et al. (2007) | |
c.688A>T | p.Lys230Ter | stop_gained | De novo | - | - | 27479843 | Lelieveld SH et al. (2016) | |
c.658C>T | p.Gln220Ter | stop_gained | De novo | - | - | 35241104 | Mouillé M et al. (2022) | |
c.703G>T | p.Glu235Ter | stop_gained | De novo | - | - | 35241104 | Mouillé M et al. (2022) | |
c.715C>T | p.Arg239Ter | stop_gained | De novo | - | - | 35241104 | Mouillé M et al. (2022) | |
c.955C>T | p.Gln319Ter | stop_gained | De novo | - | - | 35241104 | Mouillé M et al. (2022) | |
c.562C>T | p.Gln188Ter | stop_gained | Unknown | - | Simplex | 33004838 | Wang T et al. (2020) | |
c.1285C>T | p.Arg429Ter | stop_gained | De novo | - | - | 35241104 | Mouillé M et al. (2022) | |
- | - | copy_number_loss | 1 de novo, 12 unknown | - | Unknown | 25217958 | Coe BP , et al. (2014) | |
c.607T>G | p.Ser203Ala | missense_variant | Unknown | - | - | 34615535 | Mahjani B et al. (2021) | |
c.185T>A | p.Val62Asp | missense_variant | De novo | - | - | 29436146 | Zarate YA , et al. (2018) | |
c.287T>G | p.Leu96Arg | missense_variant | De novo | - | - | 29436146 | Zarate YA , et al. (2018) | |
c.285G>T | p.Gln95His | missense_variant | De novo | - | - | 31021519 | Zarate YA , et al. (2019) | |
c.715C>T | p.Arg239Ter | stop_gained | De novo | - | - | 31209962 | Aspromonte MC , et al. (2019) | |
c.715C>T | p.Arg239Ter | stop_gained | De novo | - | Simplex | 24301056 | Dcker D , et al. (2013) | |
c.392T>A | p.Val131Glu | missense_variant | De novo | - | - | 29436146 | Zarate YA , et al. (2018) | |
c.760C>T | p.His254Tyr | missense_variant | De novo | - | - | 31021519 | Zarate YA , et al. (2019) | |
c.868C>T | p.Gln290Ter | stop_gained | De novo | - | Simplex | 33644862 | Hiraide T et al. (2021) | |
c.1286G>A | p.Arg429Gln | missense_variant | De novo | - | - | 28139846 | Zarate YA , et al. (2017) | |
c.1964C>T | p.Pro655Leu | missense_variant | De novo | - | - | 28139846 | Zarate YA , et al. (2017) | |
c.1157C>T | p.Ala386Val | missense_variant | De novo | - | - | 28151491 | Bengani H , et al. (2017) | |
c.1165C>T | p.Arg389Cys | missense_variant | De novo | - | - | 28151491 | Bengani H , et al. (2017) | |
c.1181T>C | p.Leu394Ser | missense_variant | De novo | - | - | 28151491 | Bengani H , et al. (2017) | |
c.1696G>A | p.Glu566Lys | missense_variant | De novo | - | - | 28151491 | Bengani H , et al. (2017) | |
c.1165C>T | p.Arg389Cys | missense_variant | De novo | - | - | 29436146 | Zarate YA , et al. (2018) | |
c.1196G>A | p.Arg399His | missense_variant | De novo | - | - | 29436146 | Zarate YA , et al. (2018) | |
c.1286G>A | p.Arg429Gln | missense_variant | De novo | - | - | 29436146 | Zarate YA , et al. (2018) | |
c.1136A>C | p.Gln379Pro | missense_variant | De novo | - | - | 31021519 | Zarate YA , et al. (2019) | |
c.1165C>T | p.Arg389Cys | missense_variant | De novo | - | - | 31021519 | Zarate YA , et al. (2019) | |
c.1166G>T | p.Arg389Leu | missense_variant | De novo | - | - | 31021519 | Zarate YA , et al. (2019) | |
c.1169C>T | p.Thr390Ile | missense_variant | De novo | - | - | 31021519 | Zarate YA , et al. (2019) | |
c.1175G>A | p.Gly392Glu | missense_variant | De novo | - | - | 31021519 | Zarate YA , et al. (2019) | |
c.1196G>A | p.Arg399His | missense_variant | De novo | - | - | 31021519 | Zarate YA , et al. (2019) | |
c.1196G>A | p.Arg399His | missense_variant | Unknown | - | - | 31021519 | Zarate YA , et al. (2019) | |
c.1196G>T | p.Arg399Leu | missense_variant | De novo | - | - | 31021519 | Zarate YA , et al. (2019) | |
c.1253T>G | p.Met418Arg | missense_variant | De novo | - | - | 31021519 | Zarate YA , et al. (2019) | |
c.1286G>A | p.Arg429Gln | missense_variant | Unknown | - | - | 31021519 | Zarate YA , et al. (2019) | |
c.1903G>T | p.Asp635Tyr | missense_variant | De novo | - | - | 31021519 | Zarate YA , et al. (2019) | |
c.346+2T>G | - | splice_site_variant | De novo | - | Simplex | 25885067 | Zarate YA , et al. (2015) | |
- | - | complex_structural_alteration | De novo | - | - | 30923172 | Schluth-Bolard C , et al. (2019) | |
c.748C>T | p.Gln250Ter | stop_gained | De novo | - | Simplex | 25885067 | Zarate YA , et al. (2015) | |
c.847C>T | p.Arg283Ter | stop_gained | De novo | - | Simplex | 25885067 | Zarate YA , et al. (2015) | |
c.1298A>C | p.Tyr433Ser | missense_variant | De novo | - | - | 31452935 | Feliciano P et al. (2019) | |
c.346G>C | p.Gly116Arg | splice_site_variant | De novo | - | - | 28139846 | Zarate YA , et al. (2017) | |
c.1171C>T | p.Gln391Ter | stop_gained | De novo | - | Simplex | 25885067 | Zarate YA , et al. (2015) | |
c.1165C>T | p.Arg389Cys | missense_variant | De novo | - | - | 35241104 | Mouillé M et al. (2022) | |
c.1198A>G | p.Lys400Glu | missense_variant | De novo | - | - | 35241104 | Mouillé M et al. (2022) | |
c.1538G>A | p.Ser513Asn | missense_variant | De novo | - | - | 35241104 | Mouillé M et al. (2022) | |
c.1696G>A | p.Glu566Lys | missense_variant | De novo | - | - | 35241104 | Mouillé M et al. (2022) | |
c.1861A>T | p.Ile621Phe | missense_variant | De novo | - | Simplex | 30504930 | Guo H , et al. (2018) | |
c.1109A>T | p.Asp370Val | missense_variant | Unknown | - | - | 28628100 | Geisheker MR , et al. (2017) | |
c.1184C>T | p.Ser395Phe | missense_variant | De novo | - | - | 28628100 | Geisheker MR , et al. (2017) | |
c.1214G>A | p.Arg405Gln | missense_variant | Unknown | - | - | 28628100 | Geisheker MR , et al. (2017) | |
c.1639dup | p.Leu547ProfsTer5 | frameshift_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.1197dup | p.Lys400Ter | frameshift_variant | De novo | - | - | 35241104 | Mouillé M et al. (2022) | |
c.1148del | p.Ala383GlufsTer30 | frameshift_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.1728del | p.Glu577SerfsTer47 | frameshift_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.1142T>G | p.Val381Gly | missense_variant | De novo | - | Simplex | 23020937 | Rauch A , et al. (2012) | |
c.15del | p.Ser5ArgfsTer25 | frameshift_variant | Unknown | - | - | 31021519 | Zarate YA , et al. (2019) | |
c.83del | p.Pro28GlnfsTer2 | frameshift_variant | Unknown | - | - | 36475376 | Shimelis H et al. (2023) | |
c.1627del | p.Arg543AlafsTer3 | frameshift_variant | De novo | - | - | 28708303 | Chrot E , et al. (2017) | |
c.347-14689_347-14688del | - | frameshift_variant | De novo | - | - | 29436146 | Zarate YA , et al. (2018) | |
c.1285C>T | p.Arg429Ter | stop_gained | De novo | - | Simplex | 34580403 | Pode-Shakked B et al. (2021) | |
c.1375C>T | p.Arg459Ter | stop_gained | Unknown | - | Simplex | 37541188 | Sanchis-Juan A et al. (2023) | |
c.347-15118G>A | - | splice_site_variant | De novo | - | Simplex | 27848944 | Trujillano D , et al. (2016) | |
c.1536_1537del | p.Gln514GlyfsTer5 | frameshift_variant | Unknown | - | - | 39136901 | Karen Lob et al. () | |
c.583dup | p.Cys195LeufsTer14 | frameshift_variant | De novo | - | - | 28139846 | Zarate YA , et al. (2017) | |
c.583dup | p.Cys195LeufsTer14 | frameshift_variant | De novo | - | - | 28151491 | Bengani H , et al. (2017) | |
c.1203dup | p.Glu402ArgfsTer35 | frameshift_variant | De novo | - | - | 28151491 | Bengani H , et al. (2017) | |
c.1575del | p.Asn526ThrfsTer20 | frameshift_variant | De novo | - | - | 28151491 | Bengani H , et al. (2017) | |
c.1646del | p.Gln549ArgfsTer75 | frameshift_variant | De novo | - | - | 28151491 | Bengani H , et al. (2017) | |
c.1826del | p.Asp609AlafsTer15 | frameshift_variant | De novo | - | - | 34653234 | Aguilera C et al. (2021) | |
c.1657del | p.Asp553MetfsTer71 | frameshift_variant | Unknown | - | - | 36475376 | Shimelis H et al. (2023) | |
c.696dup | p.Lys233Ter | frameshift_variant | De novo | - | Simplex | 35887114 | Levchenko O et al. (2022) | |
c.1174G>A | p.Gly392Arg | missense_variant | De novo | - | Simplex | 33624935 | Abe-Hatano C et al. (2021) | |
c.347-15873_347-15872insTGGT | - | frameshift_variant | Unknown | - | - | 29436146 | Zarate YA , et al. (2018) | |
c.1610del | p.Asn537ThrfsTer9 | frameshift_variant | De novo | - | - | 35241104 | Mouillé M et al. (2022) | |
c.1627del | p.Arg543AlafsTer3 | frameshift_variant | De novo | - | - | 35241104 | Mouillé M et al. (2022) | |
c.1010dup | p.Gln338AlafsTer13 | frameshift_variant | De novo | - | - | 35241104 | Mouillé M et al. (2022) | |
c.347-15150_347-15149insCAAGCCT | - | frameshift_variant | De novo | - | - | 31021519 | Zarate YA , et al. (2019) | |
c.1131_1132del | p.Ser378ProfsTer18 | frameshift_variant | Unknown | - | - | 29436146 | Zarate YA , et al. (2018) | |
c.315_316insAC | p.Tyr106ThrfsTer13 | frameshift_variant | De novo | - | - | 31021519 | Zarate YA , et al. (2019) | |
c.1963C>T | p.Pro655Ser | missense_variant | Familial | Paternal | Simplex | 23849776 | Jiang YH , et al. (2013) | |
c.1131_1132del | p.Ser378ProfsTer18 | frameshift_variant | Unknown | - | - | 28554332 | Bowling KM , et al. (2017) | |
c.553_554insT | p.Glu185ValfsTer24 | frameshift_variant | De novo | - | - | 39039281 | Axel Schmidt et al. (2024) | |
c.1103_1106del | p.Val368GlufsTer4 | frameshift_variant | De novo | - | - | 39039281 | Axel Schmidt et al. (2024) | |
c.411_412insGACAGTGG | p.Thr138AspfsTer16 | frameshift_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.1945dup | p.Ser649PhefsTer40 | frameshift_variant | De novo | - | Simplex | 25885067 | Zarate YA , et al. (2015) | |
c.414_415del | p.Val139GlyfsTer69 | frameshift_variant | De novo | - | Simplex | 35887114 | Levchenko O et al. (2022) | |
c.598-2A>G | - | splice_site_variant | De novo (germline mosaicism) | - | Multiplex | 28151491 | Bengani H , et al. (2017) | |
c.1173+2T>C | - | splice_site_variant | De novo | - | Unknown | 25533962 | Deciphering Developmental Disorders Study (2014) | |
c.1375C>T | p.Arg459Ter | stop_gained | De novo | - | Simplex | 25533962 | Deciphering Developmental Disorders Study (2014) | |
c.1166G>T | p.Arg389Leu | missense_variant | De novo | - | Simplex | 25533962 | Deciphering Developmental Disorders Study (2014) | |
c.1196G>A | p.Arg399His | missense_variant | De novo | - | Simplex | 25533962 | Deciphering Developmental Disorders Study (2014) | |
c.1204G>A | p.Glu402Lys | missense_variant | De novo | - | Simplex | 25533962 | Deciphering Developmental Disorders Study (2014) | |
c.1543G>A | p.Gly515Ser | missense_variant | De novo | - | Simplex | 25533962 | Deciphering Developmental Disorders Study (2014) | |
c.594_595del | p.Gln199GlufsTer9 | frameshift_variant | De novo | - | Simplex | 25533962 | Deciphering Developmental Disorders Study (2014) |
Common Variants (1)
Status | Allele Change | Residue Change | Variant Type | Inheritance Pattern | Paternal Transmission | Family Type | PubMed ID | Author, Year |
---|---|---|---|---|---|---|---|---|
A>G | - | intergenic_variant | - | - | - | 29483656 | Pardias AF , et al. (2018) |
SFARI Gene score
Strong Candidate, Syndromic
This gene was identified as an ASD candidate gene following the identification of a balanced chromosomal abnormality (BCA) leading to gene disruption in an ASD case (PMID 22521361). This report also showed significant burden (P=0.001) of SATB2 CNVs in individuals with neurodevelopmental disorder (NDD; ~25% of cases with ASD). Delineation of the phenotypes associated with SATB2-associated syndrome, also referred to as Glass syndrome (OMIM 612313), determined that autistic/repetitive behaviors were observed in 7 out of 35 cases (20%) described in Zarate and Fish, 2016, whereas 4/12 (33%) additional cases in Zarate et al., 2017 were reported to present with autistic tendencies. Phenotypic characterization of 72 individuals enrolled through the SAS clinical registry, 46 of whom had not been previously published, in Zarate et al., 2018 reported that while behavioral abnormalities were observed in over 80% of cases for whom such data was available, autistic behaviors were observed in approximately 20% of individuals. A review of 158 patients with SATB2-associated syndrome, including 57 previously unreported patients, in Zarate et al., 2019 found that 20% (29/145) displayed autistic behavior.
Score Delta: Score remained at 2S
criteria met
See SFARI Gene'scoring criteriaWe considered a rigorous statistical comparison between cases and controls, yielding genome-wide statistical significance, with independent replication, to be the strongest possible evidence for a gene. These criteria were relaxed slightly for category 2.
The syndromic category includes mutations that are associated with a substantial degree of increased risk and consistently linked to additional characteristics not required for an ASD diagnosis. If there is independent evidence implicating a gene in idiopathic ASD, it will be listed as "#S" (e.g., 2S, 3S, etc.). If there is no such independent evidence, the gene will be listed simply as "S."
4/1/2022
Decreased from 3S to 2S
Description
This gene was identified as an ASD candidate gene following the identification of a balanced chromosomal abnormality (BCA) leading to gene disruption in an ASD case (PMID 22521361). This report also showed significant burden (P=0.001) of SATB2 CNVs in individuals with neurodevelopmental disorder (NDD; ~25% of cases with ASD). Delineation of the phenotypes associated with SATB2-associated syndrome, also referred to as Glass syndrome (OMIM 612313), determined that autistic/repetitive behaviors were observed in 7 out of 35 cases (20%) described in Zarate and Fish, 2016, whereas 4/12 (33%) additional cases in Zarate et al., 2017 were reported to present with autistic tendencies. Phenotypic characterization of 72 individuals enrolled through the SAS clinical registry, 46 of whom had not been previously published, in Zarate et al., 2018 reported that while behavioral abnormalities were observed in over 80% of cases for whom such data was available, autistic behaviors were observed in approximately 20% of individuals. A review of 158 patients with SATB2-associated syndrome, including 57 previously unreported patients, in Zarate et al., 2019 found that 20% (29/145) displayed autistic behavior.
4/1/2021
Decreased from 3S to 3S
Description
This gene was identified as an ASD candidate gene following the identification of a balanced chromosomal abnormality (BCA) leading to gene disruption in an ASD case (PMID 22521361). This report also showed significant burden (P=0.001) of SATB2 CNVs in individuals with neurodevelopmental disorder (NDD; ~25% of cases with ASD). Delineation of the phenotypes associated with SATB2-associated syndrome, also referred to as Glass syndrome (OMIM 612313), determined that autistic/repetitive behaviors were observed in 7 out of 35 cases (20%) described in Zarate and Fish, 2016, whereas 4/12 (33%) additional cases in Zarate et al., 2017 were reported to present with autistic tendencies. Phenotypic characterization of 72 individuals enrolled through the SAS clinical registry, 46 of whom had not been previously published, in Zarate et al., 2018 reported that while behavioral abnormalities were observed in over 80% of cases for whom such data was available, autistic behaviors were observed in approximately 20% of individuals. A review of 158 patients with SATB2-associated syndrome, including 57 previously unreported patients, in Zarate et al., 2019 found that 20% (29/145) displayed autistic behavior.
1/1/2021
Decreased from 3S to 3S
Description
This gene was identified as an ASD candidate gene following the identification of a balanced chromosomal abnormality (BCA) leading to gene disruption in an ASD case (PMID 22521361). This report also showed significant burden (P=0.001) of SATB2 CNVs in individuals with neurodevelopmental disorder (NDD; ~25% of cases with ASD). Delineation of the phenotypes associated with SATB2-associated syndrome, also referred to as Glass syndrome (OMIM 612313), determined that autistic/repetitive behaviors were observed in 7 out of 35 cases (20%) described in Zarate and Fish, 2016, whereas 4/12 (33%) additional cases in Zarate et al., 2017 were reported to present with autistic tendencies. Phenotypic characterization of 72 individuals enrolled through the SAS clinical registry, 46 of whom had not been previously published, in Zarate et al., 2018 reported that while behavioral abnormalities were observed in over 80% of cases for whom such data was available, autistic behaviors were observed in approximately 20% of individuals. A review of 158 patients with SATB2-associated syndrome, including 57 previously unreported patients, in Zarate et al., 2019 found that 20% (29/145) displayed autistic behavior.
Reports Added
[Growth, development, and phenotypic spectrum of individuals with deletions of 2q33.1 involving SATB22021] [Whole genome sequencing of 45 Japanese patients with intellectual disability2021] [Genetic and phenotypic analysis of 101 patients with developmental delay or intellectual disability using whole-exome sequencing2021]10/1/2020
Decreased from 3S to 3S
Description
This gene was identified as an ASD candidate gene following the identification of a balanced chromosomal abnormality (BCA) leading to gene disruption in an ASD case (PMID 22521361). This report also showed significant burden (P=0.001) of SATB2 CNVs in individuals with neurodevelopmental disorder (NDD; ~25% of cases with ASD). Delineation of the phenotypes associated with SATB2-associated syndrome, also referred to as Glass syndrome (OMIM 612313), determined that autistic/repetitive behaviors were observed in 7 out of 35 cases (20%) described in Zarate and Fish, 2016, whereas 4/12 (33%) additional cases in Zarate et al., 2017 were reported to present with autistic tendencies. Phenotypic characterization of 72 individuals enrolled through the SAS clinical registry, 46 of whom had not been previously published, in Zarate et al., 2018 reported that while behavioral abnormalities were observed in over 80% of cases for whom such data was available, autistic behaviors were observed in approximately 20% of individuals. A review of 158 patients with SATB2-associated syndrome, including 57 previously unreported patients, in Zarate et al., 2019 found that 20% (29/145) displayed autistic behavior.
4/1/2020
Decreased from 3S to 3S
Description
This gene was identified as an ASD candidate gene following the identification of a balanced chromosomal abnormality (BCA) leading to gene disruption in an ASD case (PMID 22521361). This report also showed significant burden (P=0.001) of SATB2 CNVs in individuals with neurodevelopmental disorder (NDD; ~25% of cases with ASD). Delineation of the phenotypes associated with SATB2-associated syndrome, also referred to as Glass syndrome (OMIM 612313), determined that autistic/repetitive behaviors were observed in 7 out of 35 cases (20%) described in Zarate and Fish, 2016, whereas 4/12 (33%) additional cases in Zarate et al., 2017 were reported to present with autistic tendencies. Phenotypic characterization of 72 individuals enrolled through the SAS clinical registry, 46 of whom had not been previously published, in Zarate et al., 2018 reported that while behavioral abnormalities were observed in over 80% of cases for whom such data was available, autistic behaviors were observed in approximately 20% of individuals. A review of 158 patients with SATB2-associated syndrome, including 57 previously unreported patients, in Zarate et al., 2019 found that 20% (29/145) displayed autistic behavior.
10/1/2019
Decreased from 4S to 3S
New Scoring Scheme
Description
This gene was identified as an ASD candidate gene following the identification of a balanced chromosomal abnormality (BCA) leading to gene disruption in an ASD case (PMID 22521361). This report also showed significant burden (P=0.001) of SATB2 CNVs in individuals with neurodevelopmental disorder (NDD; ~25% of cases with ASD). Delineation of the phenotypes associated with SATB2-associated syndrome, also referred to as Glass syndrome (OMIM 612313), determined that autistic/repetitive behaviors were observed in 7 out of 35 cases (20%) described in Zarate and Fish, 2016, whereas 4/12 (33%) additional cases in Zarate et al., 2017 were reported to present with autistic tendencies. Phenotypic characterization of 72 individuals enrolled through the SAS clinical registry, 46 of whom had not been previously published, in Zarate et al., 2018 reported that while behavioral abnormalities were observed in over 80% of cases for whom such data was available, autistic behaviors were observed in approximately 20% of individuals. A review of 158 patients with SATB2-associated syndrome, including 57 previously unreported patients, in Zarate et al., 2019 found that 20% (29/145) displayed autistic behavior.
7/1/2019
Decreased from 4S to 4S
Description
This gene was identified as an ASD candidate gene following the identification of a balanced chromosomal abnormality (BCA) leading to gene disruption in an ASD case (PMID 22521361). This report also showed significant burden (P=0.001) of SATB2 CNVs in individuals with neurodevelopmental disorder (NDD; ~25% of cases with ASD). Delineation of the phenotypes associated with SATB2-associated syndrome, also referred to as Glass syndrome (OMIM 612313), determined that autistic/repetitive behaviors were observed in 7 out of 35 cases (20%) described in Zarate and Fish, 2016, whereas 4/12 (33%) additional cases in Zarate et al., 2017 were reported to present with autistic tendencies. Phenotypic characterization of 72 individuals enrolled through the SAS clinical registry, 46 of whom had not been previously published, in Zarate et al., 2018 reported that while behavioral abnormalities were observed in over 80% of cases for whom such data was available, autistic behaviors were observed in approximately 20% of individuals. A review of 158 patients with SATB2-associated syndrome, including 57 previously unreported patients, in Zarate et al., 2019 found that 20% (29/145) displayed autistic behavior.
4/1/2019
Decreased from 4S to 4S
Description
This gene was identified as an ASD candidate gene following the identification of a balanced chromosomal abnormality (BCA) leading to gene disruption in an ASD case (PMID 22521361). This report also showed significant burden (P=0.001) of SATB2 CNVs in individuals with neurodevelopmental disorder (NDD; ~25% of cases with ASD). Delineation of the phenotypes associated with SATB2-associated syndrome, also referred to as Glass syndrome (OMIM 612313), determined that autistic/repetitive behaviors were observed in 7 out of 35 cases (20%) described in Zarate and Fish, 2016, whereas 4/12 (33%) additional cases in Zarate et al., 2017 were reported to present with autistic tendencies. Phenotypic characterization of 72 individuals enrolled through the SAS clinical registry, 46 of whom had not been previously published, in Zarate et al., 2018 reported that while behavioral abnormalities were observed in over 80% of cases for whom such data was available, autistic behaviors were observed in approximately 20% of individuals.
Reports Added
[Whole genome paired-end sequencing elucidates functional and phenotypic consequences of balanced chromosomal rearrangement in patients with develop...2019] [The combination of whole-exome sequencing and copy number variation sequencing enables the diagnosis of rare neurological disorders.2019] [Mutation update for the SATB2 gene.2019]10/1/2018
Decreased from 4S to 4S
Description
This gene was identified as an ASD candidate gene following the identification of a balanced chromosomal abnormality (BCA) leading to gene disruption in an ASD case (PMID 22521361). This report also showed significant burden (P=0.001) of SATB2 CNVs in individuals with neurodevelopmental disorder (NDD; ~25% of cases with ASD). Delineation of the phenotypes associated with SATB2-associated syndrome, also referred to as Glass syndrome (OMIM 612313), determined that autistic/repetitive behaviors were observed in 7 out of 35 cases (20%) described in Zarate and Fish, 2016, whereas 4/12 (33%) additional cases in Zarate et al., 2017 were reported to present with autistic tendencies. Phenotypic characterization of 72 individuals enrolled through the SAS clinical registry, 46 of whom had not been previously published, in Zarate et al., 2018 reported that while behavioral abnormalities were observed in over 80% of cases for whom such data was available, autistic behaviors were observed in approximately 20% of individuals.
7/1/2018
Decreased from 4S to 4S
Description
This gene was identified as an ASD candidate gene following the identification of a balanced chromosomal abnormality (BCA) leading to gene disruption in an ASD case (PMID 22521361). This report also showed significant burden (P=0.001) of SATB2 CNVs in individuals with neurodevelopmental disorder (NDD; ~25% of cases with ASD). Delineation of the phenotypes associated with SATB2-associated syndrome, also referred to as Glass syndrome (OMIM 612313), determined that autistic/repetitive behaviors were observed in 7 out of 35 cases (20%) described in Zarate and Fish, 2016, whereas 4/12 (33%) additional cases in Zarate et al., 2017 were reported to present with autistic tendencies. Phenotypic characterization of 72 individuals enrolled through the SAS clinical registry, 46 of whom had not been previously published, in Zarate et al., 2018 reported that while behavioral abnormalities were observed in over 80% of cases for whom such data was available, autistic behaviors were observed in approximately 20% of individuals.
7/1/2017
Decreased from 4S to 4S
Description
This gene was identified as an ASD candidate gene following the identification of a balanced chromosomal abnormality (BCA) leading to gene disruption in an ASD case (PMID 22521361). This report also showed significant burden (P=0.001) of SATB2 CNVs in individuals with neurodevelopmental disorder (NDD; ~25% of cases with ASD). Delineation of the phenotypes associated with SATB2-associated syndrome, also referred to as Glass syndrome (OMIM 612313), determined that autistic/repetitive behaviors were observed in 7 out of 35 cases (20%) described in Zarate and Fish, 2016, whereas 4/12 (33%) additional cases in Zarate et al., 2017 were reported to present with autistic tendencies.
4/1/2017
Decreased from 4S to 4S
Description
This gene was identified as an ASD candidate gene following the identification of a balanced chromosomal abnormality (BCA) leading to gene disruption in an ASD case (PMID 22521361). This report also showed significant burden (P=0.001) of SATB2 CNVs in individuals with neurodevelopmental disorder (NDD; ~25% of cases with ASD). Delineation of the phenotypes associated with SATB2-associated syndrome, also referred to as Glass syndrome (OMIM 612313), determined that autistic/repetitive behaviors were observed in 7 out of 35 cases (20%) described in Zarate and Fish, 2016, whereas 4/12 (33%) additional cases in Zarate et al., 2017 were reported to present with autistic tendencies.
Reports Added
[Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries.2012] [Detection of clinically relevant genetic variants in autism spectrum disorder by whole-genome sequencing.2013] [Refining analyses of copy number variation identifies specific genes associated with developmental delay.2014] [Further delineation of the SATB2 phenotype.2013] [Large-scale discovery of novel genetic causes of developmental disorders.2014] [Heterozygous nonsense mutation SATB2 associated with cleft palate, osteoporosis, and cognitive defects.2007] [Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study.2012] [Further supporting evidence for the SATB2-associated syndrome found through whole exome sequencing.2015] [A molecular model for neurodevelopmental disorders.2015] [Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability2016] [SATB2-associated syndrome: Mechanisms, phenotype, and practical recommendations.2016] [Clinical exome sequencing: results from 2819 samples reflecting 1000 families.2016] [The genomic landscape of balanced cytogenetic abnormalities associated with human congenital anomalies.2016] [Genotype and phenotype in 12 additional individuals with SATB2-associated syndrome.2017] [Clinical and molecular consequences of disease-associated de novo mutations in SATB2.2017] [A clinical utility study of exome sequencing versus conventional genetic testing in pediatric neurology.2017] [Genomic diagnosis for children with intellectual disability and/or developmental delay.2017]1/1/2017
Decreased from 4S to 4S
Description
This gene was identified as an ASD candidate gene following the identification of a balanced chromosomal abnormality (BCA) leading to gene disruption in an ASD case (PMID 22521361). This report also showed significant burden (P=0.001) of SATB2 CNVs in individuals with neurodevelopmental disorder (NDD; ~25% of cases with ASD). Delineation of the phenotypes associated with SATB2-associated syndrome, also referred to as Glass syndrome (OMIM 612313), determined that autistic/repetitive behaviors were observed in 7 out of 35 cases (20%) described in Zarate and Fish, 2016, whereas 4/12 (33%) additional cases in Zarate et al., 2017 were reported to present with autistic tendencies.
10/1/2016
Decreased from 4 to 4S
Description
This gene was identified as an ASD candidate gene following the identification of a balanced chromosomal abnormality (BCA) leading to gene disruption in an ASD case (PMID 22521361). This report also showed significant burden (P=0.001) of SATB2 CNVs in individuals with neurodevelopmental disorder (NDD; ~25% of cases with ASD). Delineation of the phenotypes associated with SATB2-associated syndrome, also referred to as Glass syndrome (OMIM 612313), determined that autistic/repetitive behaviors were observed in 7 out of 35 cases (20%) described in Zarate and Fish, 2016.
7/1/2016
Decreased from 4 to 4
Description
This gene was identified as an ASD candidate gene following the identification of a balanced chromosomal abnormality (BCA) leading to gene disruption in an ASD case (PMID 22521361). This report also showed significant burden (P=0.001) of SATB2 CNVs in individuals with neurodevelopmental disorder (NDD; ~25% of cases with ASD).
4/1/2015
Decreased from 4 to 4
Description
This gene was identified as an ASD candidate gene following the identification of a balanced chromosomal abnormality (BCA) leading to gene disruption in an ASD case (PMID 22521361). This report also showed significant burden (P=0.001) of SATB2 CNVs in individuals with neurodevelopmental disorder (NDD; ~25% of cases with ASD).
1/1/2015
Decreased from 4 to 4
Description
This gene was identified as an ASD candidate gene following the identification of a balanced chromosomal abnormality (BCA) leading to gene disruption in an ASD case (PMID 22521361). This report also showed significant burden (P=0.001) of SATB2 CNVs in individuals with neurodevelopmental disorder (NDD; ~25% of cases with ASD).
10/1/2014
Decreased from 4 to 4
Description
This gene was identified as an ASD candidate gene following the identification of a balanced chromosomal abnormality (BCA) leading to gene disruption in an ASD case (PMID 22521361). This report also showed significant burden (P=0.001) of SATB2 CNVs in individuals with neurodevelopmental disorder (NDD; ~25% of cases with ASD).
7/1/2014
Increased from No data to 4
Description
This gene was identified as an ASD candidate gene following the identification of a balanced chromosomal abnormality (BCA) leading to gene disruption in an ASD case (PMID 22521361). This report also showed significant burden (P=0.001) of SATB2 CNVs in individuals with neurodevelopmental disorder (NDD; ~25% of cases with ASD).
4/1/2014
Increased from No data to 4
Description
This gene was identified as an ASD candidate gene following the identification of a balanced chromosomal abnormality (BCA) leading to gene disruption in an ASD case (PMID 22521361). This report also showed significant burden (P=0.001) of SATB2 CNVs in individuals with neurodevelopmental disorder (NDD; ~25% of cases with ASD).
Krishnan Probability Score
Score 0.61589361421768
Ranking 108/25841 scored genes
[Show Scoring Methodology]
ExAC Score
Score 0.99956300698079
Ranking 906/18225 scored genes
[Show Scoring Methodology]
Sanders TADA Score
Score 0.9392038501763
Ranking 14128/18665 scored genes
[Show Scoring Methodology]
Larsen Cumulative Evidence Score
Score 10
Ranking 191/461 scored genes
[Show Scoring Methodology]
Zhang D Score
Score 0.39892754689767
Ranking 1476/20870 scored genes
[Show Scoring Methodology]
External PIN Data
Interactome
- Protein Binding
- DNA Binding
- RNA Binding
- Protein Modification
- Direct Regulation
- ASD-Linked Genes
Interaction Table
Interactor Symbol | Interactor Name | Interactor Organism | Interactor Type | Entrez ID | Uniprot ID |
---|---|---|---|---|---|
Bglap | bone gamma carboxyglutamate protein | Mouse | DNA Binding | 12096 | P86546 |
HBG1 | hemoglobin, gamma A | Human | DNA Binding | 3047 | D9YZU8 |
HSFY1 | Heat shock transcription factor, Y-linked | Human | Protein Binding | 159119 | Q96LI6 |
Mir24-2 | microRNA 24-2 | Mouse | RNA Binding | 723960 | N/A |
Mir27a | microRNA 27a | Mouse | RNA Binding | 387220 | N/A |
TP63 | tumor protein p63 | Human | Protein Binding | 8626 | Q9H3D4 |